Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases. | Eur Heart J Cardiovasc Pharmacother | 2023 | 37562936 | PubTator, text mining | PubMed |
| The effect of leukocyte- and platelet-rich fibrin on the bone loss and primary stability of implants placed in posterior maxilla: a randomized clinical trial. | Int J Implant Dent | 2023 | 37555894 | PubTator, text mining | PubMed |
| Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. | World J Gastrointest Oncol | 2023 | 37546556 | PubTator, text mining | PubMed |
| Human retinal secretome: A cross-link between mesenchymal and retinal cells. | World J Stem Cells | 2023 | 37545752 | PubTator, text mining | PubMed |
| SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment. | Heliyon | 2023 | 37539189 | PubTator, text mining | PubMed |
| Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells. | BMC Ophthalmol | 2023 | 37537538 | PubTator, text mining | PubMed |
| Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes. | Cell Rep | 2023 | 37531253 | PubTator, text mining | PubMed |
| HMGB1, a potential regulator of tumor microenvironment in KSHV-infected endothelial cells. | Front Microbiol | 2023 | 37520371 | PubTator, text mining | PubMed |
| Prevention and Treatment of Retinal Vein Occlusion: The Role of Diet-A Review. | Nutrients | 2023 | 37513655 | PubTator, text mining | PubMed |
| Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. | Biomedicines | 2023 | 37509725 | PubTator, text mining | PubMed |
| Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures: A Narrative Review. | Biomedicines | 2023 | 37509560 | PubTator, text mining | PubMed |
| Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets. | Cells | 2023 | 37508582 | PubTator, text mining | PubMed |
| Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia. | Sci Rep | 2023 | 37507442 | PubTator, text mining | PubMed |
| Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis. | Front Immunol | 2023 | 37497234 | PubTator, text mining | PubMed |
| Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions. | Cancer Sci | 2023 | 37480223 | PubTator, text mining | PubMed |
| Identification of mitochondrial-related genes as potential biomarkers for the subtyping and prediction of Alzheimer's disease. | Front Mol Neurosci | 2023 | 37470054 | PubTator, text mining | PubMed |
| Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma. | Mediators Inflamm | 2023 | 37469759 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation. | Front Immunol | 2023 | 37457701 | PubTator, text mining | PubMed |
| A large-scale Boolean model of the rheumatoid arthritis fibroblast-like synoviocytes predicts drug synergies in the arthritic joint. | NPJ Syst Biol Appl | 2023 | 37454172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=15